Characterisation of cardiac pathology in 23 autopsies of lethal COVID-19. 2021

Jasmin D Haslbauer, and Alexandar Tzankov, and Kirsten D Mertz, and Nathalie Schwab, and Ronny Nienhold, and Raphael Twerenbold, and Gregor Leibundgut, and Anna K Stalder, and Matthias Matter, and Katharina Glatz
Pathology, Institute of Medical Genetics and Pathology, University Hospital Basel, University of Basel, Basel, Switzerland.

While coronavirus disease 2019 (COVID-19) primarily affects the respiratory tract, pathophysiological changes of the cardiovascular system remain to be elucidated. We performed a retrospective cardiopathological analysis of the heart and vasculature from 23 autopsies of COVID-19 patients, comparing the findings with control tissue. Myocardium from autopsies of COVID-19 patients was categorised into severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positive (n = 14) or negative (n = 9) based on the presence of viral RNA as determined by reverse transcriptase polymerase chain reaction (RT-PCR). Control tissue was selected from autopsies without COVID-19 (n = 10) with similar clinical sequelae. Histological characteristics were scored by ordinal and/or categorical grading. Five RT-PCR-positive cases underwent in situ hybridisation (ISH) for SARS-CoV-2. Patients with lethal COVID-19 infection were mostly male (78%) and had a high incidence of hypertension (91%), coronary artery disease (61%), and diabetes mellitus (48%). Patients with positive myocardial RT-PCR died earlier after hospital admission (5 versus 12 days, p < 0.001) than patients with negative RT-PCR. An increased severity of fibrin deposition, capillary dilatation, and microhaemorrhage was observed in RT-PCR-positive myocardium than in negatives and controls, with a positive correlation amongst these factors All cases with increased cardioinflammatory infiltrate, without myocyte necrosis (n = 4) or with myocarditis (n = 1), were RT-PCR negative. ISH revealed positivity of viral RNA in interstitial cells. Myocardial capillary dilatation, fibrin deposition, and microhaemorrhage may be the histomorphological correlate of COVID-19-associated coagulopathy. Increased cardioinflammation including one case of myocarditis was only detected in RT-PCR-negative hearts with significantly longer hospitalisation time. This may imply a secondary immunological response warranting further characterisation.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009205 Myocarditis Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies. Carditis,Myocarditides
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D012137 Respiratory System The tubular and cavernous organs and structures, by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about. Respiratory Tract,Respiratory Systems,Respiratory Tracts,System, Respiratory,Tract, Respiratory
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Jasmin D Haslbauer, and Alexandar Tzankov, and Kirsten D Mertz, and Nathalie Schwab, and Ronny Nienhold, and Raphael Twerenbold, and Gregor Leibundgut, and Anna K Stalder, and Matthias Matter, and Katharina Glatz
April 2022, Irish journal of medical science,
Jasmin D Haslbauer, and Alexandar Tzankov, and Kirsten D Mertz, and Nathalie Schwab, and Ronny Nienhold, and Raphael Twerenbold, and Gregor Leibundgut, and Anna K Stalder, and Matthias Matter, and Katharina Glatz
September 1990, Journal of forensic sciences,
Jasmin D Haslbauer, and Alexandar Tzankov, and Kirsten D Mertz, and Nathalie Schwab, and Ronny Nienhold, and Raphael Twerenbold, and Gregor Leibundgut, and Anna K Stalder, and Matthias Matter, and Katharina Glatz
October 1992, Clinical cardiology,
Jasmin D Haslbauer, and Alexandar Tzankov, and Kirsten D Mertz, and Nathalie Schwab, and Ronny Nienhold, and Raphael Twerenbold, and Gregor Leibundgut, and Anna K Stalder, and Matthias Matter, and Katharina Glatz
January 2020, Frontiers in cardiovascular medicine,
Jasmin D Haslbauer, and Alexandar Tzankov, and Kirsten D Mertz, and Nathalie Schwab, and Ronny Nienhold, and Raphael Twerenbold, and Gregor Leibundgut, and Anna K Stalder, and Matthias Matter, and Katharina Glatz
May 2020, American journal of clinical pathology,
Jasmin D Haslbauer, and Alexandar Tzankov, and Kirsten D Mertz, and Nathalie Schwab, and Ronny Nienhold, and Raphael Twerenbold, and Gregor Leibundgut, and Anna K Stalder, and Matthias Matter, and Katharina Glatz
July 2020, Autopsy & case reports,
Jasmin D Haslbauer, and Alexandar Tzankov, and Kirsten D Mertz, and Nathalie Schwab, and Ronny Nienhold, and Raphael Twerenbold, and Gregor Leibundgut, and Anna K Stalder, and Matthias Matter, and Katharina Glatz
November 2021, Der Pathologe,
Jasmin D Haslbauer, and Alexandar Tzankov, and Kirsten D Mertz, and Nathalie Schwab, and Ronny Nienhold, and Raphael Twerenbold, and Gregor Leibundgut, and Anna K Stalder, and Matthias Matter, and Katharina Glatz
March 2021, Der Pathologe,
Jasmin D Haslbauer, and Alexandar Tzankov, and Kirsten D Mertz, and Nathalie Schwab, and Ronny Nienhold, and Raphael Twerenbold, and Gregor Leibundgut, and Anna K Stalder, and Matthias Matter, and Katharina Glatz
March 2021, Der Pathologe,
Jasmin D Haslbauer, and Alexandar Tzankov, and Kirsten D Mertz, and Nathalie Schwab, and Ronny Nienhold, and Raphael Twerenbold, and Gregor Leibundgut, and Anna K Stalder, and Matthias Matter, and Katharina Glatz
November 2020, Legal medicine (Tokyo, Japan),
Copied contents to your clipboard!